145 related articles for article (PubMed ID: 5639696)
1. Antigenic properties of mouse lymphoma cells.
Hays EF
J Immunol; 1968 Feb; 100(2):245-51. PubMed ID: 5639696
[No Abstract] [Full Text] [Related]
2. Immune response to Gross virus-induced lymphoma. II. Kinetics of the cellular immune response.
Oren ME; Herberman RB; Canty TG
J Natl Cancer Inst; 1971 Mar; 46(3):621-8. PubMed ID: 5547316
[No Abstract] [Full Text] [Related]
3. Cross-resistance to the transplantation of syngeneic Friend, Moloney, and Rauscher virus-induced tumors.
Glynn JP; McCoy JL; Fefer A
Cancer Res; 1968 Mar; 28(3):434-9. PubMed ID: 4867923
[No Abstract] [Full Text] [Related]
4. Influence of infectious virus on the induction of transplantation resistance in the Friend tumor system.
McCoy JL; Fefer A; Glynn JP
Cancer Res; 1967 Dec; 27(12):2267-71. PubMed ID: 4866760
[No Abstract] [Full Text] [Related]
5. Antigenic characterization of heterozygous mouse lymphomas after immunoselection in vivo.
Bjaring B; Klein G
J Natl Cancer Inst; 1968 Dec; 41(6):1411-29. PubMed ID: 4882575
[No Abstract] [Full Text] [Related]
6. Selection of an immunoresistant Moloney lymphoma subline with decreased concentration of tumor-specific surface antigens.
Fenyö EM; Klein E; Klein G; Swiech K
J Natl Cancer Inst; 1968 Jan; 40(1):69-89. PubMed ID: 4864597
[No Abstract] [Full Text] [Related]
7. Spontaneous breakdown of immunological tolerance to Gross-virus-induced cell-surface antigens in the rat.
Kuzumaki N; Takeichi N; Kodama T; Kobayashi H
Int J Cancer; 1973 Sep; 12(2):389-95. PubMed ID: 4799770
[No Abstract] [Full Text] [Related]
8. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
Fass L; Fefer A
Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
[No Abstract] [Full Text] [Related]
9. Antigenic expression as a determining factor of tumor growth in Gross' virus lymphoma.
Ioachim HL; Keller S; Sabbath M; Dorsett B
Prog Exp Tumor Res; 1974; 19():284-96. PubMed ID: 4373783
[No Abstract] [Full Text] [Related]
10. Immunological stimulation with modified lymphoma cells in a minimally responsive tumor-host system.
Prager MD; Baechtel FS; Ribble RJ; Ludden CM; Mehta JM
Cancer Res; 1974 Dec; 34(12):3203-9. PubMed ID: 4429949
[No Abstract] [Full Text] [Related]
11. Enhancement of lymphoma cell immunogenicity by infection with nononcogenic virus.
Eaton MD; Heller JA; Scala AR
Cancer Res; 1973 Dec; 33(12):3293-8. PubMed ID: 4357358
[No Abstract] [Full Text] [Related]
12. Heterogenization of normal tissues in oncogenesis. A skeptical review.
Mariani T; Good RA
Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
[No Abstract] [Full Text] [Related]
13. Suppression of Gross leukemia cell-surface antigens: a kind of antigenic modulation.
Aoki T; Johnson PA
J Natl Cancer Inst; 1972 Jul; 49(1):183-92. PubMed ID: 5037434
[No Abstract] [Full Text] [Related]
14. Variation of antigenic characteristics between different mouse lymphomas induced by the Moloney virus.
Klein G; Klein E; Haughton G
J Natl Cancer Inst; 1966 Apr; 36(4):607-21. PubMed ID: 4286935
[No Abstract] [Full Text] [Related]
15. Graft-versus-host reactions and the viral induction of mouse lymphoma.
Hays EF
Cancer Res; 1972 Feb; 32(2):270-5. PubMed ID: 4400464
[No Abstract] [Full Text] [Related]
16. Transplantability, immunological unresponsiveness, and loss of cellular antigenicity in gross virus lymphoma.
Ioachim HL; Keller SE; Dorsett BH
Bibl Haematol; 1975; (40):301-10. PubMed ID: 51627
[TBL] [Abstract][Full Text] [Related]
17. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
Finklestein JZ; Byfield J; Tittle K; Imagawa DT
Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
[No Abstract] [Full Text] [Related]
18. Depression of antilymphoma allograft reactivity by tumor-associated factors.
Bonmassar E; Bonmassar A; Goldin A; Cudkowicz G
Cancer Res; 1973 May; 33(5):1054-61. PubMed ID: 4703118
[No Abstract] [Full Text] [Related]
19. Studies on the mechanism of isoantigenic variant formation in heterozygous mouse tumors. IV. H-2 component analysis of an (A-Sn x A.SW)F1 lymphoma.
Ozer HL; Klein G; Ozer JH
J Natl Cancer Inst; 1966 Feb; 36(2):233-47. PubMed ID: 5325483
[No Abstract] [Full Text] [Related]
20. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
Gerlier D; Bakouche O; Dore JF
J Immunol; 1983 Jul; 131(1):485-90. PubMed ID: 6190925
[No Abstract] [Full Text] [Related]
[Next] [New Search]
